Literature DB >> 33505422

Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches.

Huaping Chen1, Junrong Wu2, Liuyi Lu1, Zuojian Hu1, Xi Li1, Li Huang1, Xiaolian Zhang1, Mingxing Chen1, Xue Qin1, Li Xie3.   

Abstract

AIMS: In the cancer-related research field, there is currently a major need for a greater number of valuable biomarkers to predict the prognosis of hepatocellular carcinoma (HCC). In this study, we aimed to screen hub genes related to immune cell infiltration and explore their prognostic value for HCC.
METHODS: We analyzed five datasets (GSE46408, GSE57957, GSE74656, GSE76427, and GSE87630) from the Gene Expression Omnibus database to screen the differentially expressed genes (DEGs). A protein-protein interaction network of the DEGs was constructed using the Search Tool for the Retrieval of Interacting Genes; then, the hub genes were identified. Functional enrichment of the genes was performed on the Metascape website. Next, the expression of these hub genes was validated in several databases, including Oncomine, Gene Expression Profiling Interactive Analysis 2 (GEPIA2), and Human Protein Atlas. We explored the correlations between the hub genes and infiltrated immune cells in the TIMER2.0 database. The survival curves were generated in GEPIA2, and the univariate and multivariate Cox regression analyses were performed using TIMER2.0.
RESULTS: The top ten hub genes [DNA topoisomerase II alpha (TOP2A), cyclin B2 (CCNB2), protein regulator of cytokinesis 1 (PRC1), Rac GTPase-activating protein 1 (RACGAP1), aurora kinase A (AURKA), cyclin-dependent kinase inhibitor 3 (CDKN3), nucleolar and spindle-associated protein 1 (NUSAP1), cell division cycle-associated 5 (CDCA5), abnormal spindle microtubule assembly (ASPM), and non-SMC condensin I complex subunit G (NCAPG)] were identified in subsequent analysis. These genes are most markedly enriched in cell division, suggesting their close association with tumorigenesis. Multi-database analyses validated that the hub genes were upregulated in HCC tissues. All hub genes positively correlated with several types of immune infiltration, including B cells, CD4+ T cells, macrophages, and dendritic cells. Furthermore, these hub genes served as independent prognostic factors, and the expression of these hub genes combing with the macrophage levels could help predict an unfavorable prognosis of HCC.
CONCLUSION: In sum, these hub genes (TOP2A, CCNB2, PRC1, RACGAP1, AURKA, CDKN3, NUSAP1, CDCA5, ASPM, and NCAPG) may be pivotal markers for prognostic prediction as well as potentially work as targets for immune-based intervention strategies in HCC.
Copyright © 2021 Chen, Wu, Lu, Hu, Li, Huang, Zhang, Chen, Qin and Xie.

Entities:  

Keywords:  biomarker; hepatocellular carcinoma; immune infiltration; prognosis; tumor-associated macrophage

Year:  2021        PMID: 33505422      PMCID: PMC7831279          DOI: 10.3389/fgene.2020.575762

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  63 in total

1.  Strong correlation between ASPM gene expression and HCV cirrhosis progression identified by co-expression analysis.

Authors:  Fan Wang; Ying Chang; Jin Li; Hongling Wang; Rui Zhou; Jian Qi; Jing Liu; Qiu Zhao
Journal:  Dig Liver Dis       Date:  2016-11-04       Impact factor: 4.088

Review 2.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

3.  Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.

Authors:  Xiaoping Zhao; Xiaoying Wang; Yu You; Diguang Wen; Zhihao Feng; Yun Zhou; Keting Que; Jianping Gong; Zuojin Liu
Journal:  Exp Cell Res       Date:  2020-04-01       Impact factor: 3.905

4.  Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Hiroshi Imamura; Yutaka Matsuyama; Eiji Tanaka; Takao Ohkubo; Kiyoshi Hasegawa; Shinichi Miyagawa; Yasuhiko Sugawara; Masami Minagawa; Tadatoshi Takayama; Seiji Kawasaki; Masatoshi Makuuchi
Journal:  J Hepatol       Date:  2003-02       Impact factor: 25.083

Review 5.  Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

Authors:  Louise N Johnson; Erika De Moliner; Nick R Brown; Haiwei Song; David Barford; Jane A Endicott; Martin E M Noble
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

6.  Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma.

Authors:  Hana Park; Jun Yong Park
Journal:  Biomed Res Int       Date:  2013-12-29       Impact factor: 3.411

7.  Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer.

Authors:  Rui Zhou; Jingwen Zhang; Dongqiang Zeng; Huiying Sun; Xiaoxiang Rong; Min Shi; Jianping Bin; Yulin Liao; Wangjun Liao
Journal:  Cancer Immunol Immunother       Date:  2018-12-19       Impact factor: 6.968

8.  Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma.

Authors:  Xi Ma; Lin Zhou; Shusen Zheng
Journal:  PeerJ       Date:  2020-04-08       Impact factor: 2.984

9.  Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis.

Authors:  Dengchuan Wang; Jun Liu; Shengshuo Liu; Wenli Li
Journal:  Front Genet       Date:  2020-04-24       Impact factor: 4.599

10.  Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.

Authors:  Zengyuan Zhou; Yuzheng Li; Haiyue Hao; Yuanyuan Wang; Zihao Zhou; Zhipeng Wang; Xia Chu
Journal:  Cell Transplant       Date:  2019-12-11       Impact factor: 4.064

View more
  8 in total

1.  Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors.

Authors:  Tiantian Gao; Lei Zhao; Fan Zhang; Conghui Cao; Shuting Fan; Xiaoguang Shi
Journal:  World J Surg Oncol       Date:  2022-06-16       Impact factor: 3.253

2.  Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis.

Authors:  Qian Chen; Sibo Yang; Yewei Zhang; Bo Li; Huanming Xu; Shi Zuo
Journal:  Biomed Res Int       Date:  2022-01-28       Impact factor: 3.411

3.  Identification of Immune-Related Breast Cancer Chemotherapy Resistance Genes via Bioinformatics Approaches.

Authors:  Yabing Du; Yikai Han; Xin Wang; Huanrong Wang; Yanhong Qu; Kaiyuan Guo; Wang Ma; Lijun Fu
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244

4.  Identification of HMOX1 as a Critical Ferroptosis-Related Gene in Atherosclerosis.

Authors:  Daiqian Wu; Qian Hu; Yuqing Wang; Mengying Jin; Ziqi Tao; Jing Wan
Journal:  Front Cardiovasc Med       Date:  2022-04-14

5.  Up-Regulation of RACGAP1 Promotes Progressions of Hepatocellular Carcinoma Regulated by GABPA via PI3K/AKT Pathway.

Authors:  Yang Gu; Baiyang Chen; Deliang Guo; Leyu Pan; Xiaofeng Luo; Jie Tang; Weihua Yang; Yuxian Zhang; Liangqiang Zhang; Jingwen Huang; Rui Duan; Zhigang Wang
Journal:  Oxid Med Cell Longev       Date:  2022-08-02       Impact factor: 7.310

6.  Comprehensive Analysis of Genomic and Expression Data Identified Potential Markers for Predicting Prognosis and Immune Response in CRC.

Authors:  Yongshan He; Xuan Dai; Yuanyuan Chen; Shiyong Huang
Journal:  Genet Res (Camb)       Date:  2022-07-30       Impact factor: 1.375

7.  Identification of biomarkers related to tumorigenesis and prognosis in breast cancer.

Authors:  Xuelaiti Paizula; Daniyaerjiang Mutailipu; Wenting Xu; Hu Wang; Lina Yi
Journal:  Gland Surg       Date:  2022-09

8.  A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma.

Authors:  Lisa Su; Genhao Zhang; Xiangdong Kong
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.